Open access
Sep 2026
Mapping First In Vivo Ebolavirus Infection Events
This work demonstrates first in vivo use of EBOV trVLPs and provides proof of concept for their use as an in vivo BSL2 model to more rapidly develop antiviral agents and vaccines.
Jia-Ni Liu, Brady N. Zell, Lin Wang et al.
· bioRxiv · 0 citations